UIM
ALNY icon

USS Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

USS Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
34,492
+7,644
+28% +$2.31M 0.04% 294
2026
Q1 		$8.88M Buy
26,848
+624
+2% +$212K 0.03% 256
2025
Q4 		$10.4M Sell
26,224
-142
-0.5% -$62.8K 0.05% 215
2025
Q3 		$12M Hold
26,366
– – 0.05% 194
2025
Q2 		$8.59M Hold
26,366
– – 0.05% 234
2025
Q1 		$7.12M Hold
26,366
– – 0.05% 254
2024
Q4 		$6.21M Sell
26,366
-6,505
-20% -$1.71M 0.04% 332
2024
Q3 		$9.04M Sell
32,871
-3,976
-11% -$1.04M 0.07% 266
2024
Q2 		$8.96M Buy
36,847
+1,433
+4% +$226K 0.07% 226
2024
Q1 		$5.29M Buy
35,414
+3,712
+12% +$619K 0.04% 370
2023
Q4 		$6.07M Sell
31,702
-2,529
-7% -$431K 0.05% 312
2023
Q3 		$6.06M Buy
34,231
+4,206
+14% +$802K 0.07% 307
2023
Q2 		$5.71M Hold
30,025
– – 0.07% 320
2023
Q1 		$6.01M Sell
30,025
-1,209
-4% -$254K 0.08% 285
2022
Q4 		$7.42M Sell
31,234
-45,569
-59% -$9.72M 0.1% 225
2022
Q3 		$15.4M Sell
76,803
-363
-0.5% -$69.2K 0.22% 96
2022
Q2 		$11.3M Sell
77,166
-2,796
-3% -$397K 0.11% 189
2022
Q1 		$13.1M Buy
79,962
+4,222
+6% +$643K 0.11% 199
2021
Q4 		$12.9M Hold
75,740
– – 0.1% 205
2021
Q3 		$14.3M Buy
75,740
+18,882
+33% +$3.54M 0.12% 177
2021
Q2 		$9.63M Buy
56,858
+49,900
+717% +$7.31M 0.08% 168
2021
Q1 		$983K Hold
6,958
– – 0.01% 511
2020
Q4 		$905K Hold
6,958
– – 0.01% 509
2020
Q3 		$1.01M Hold
6,958
– – 0.01% 470
2020
Q2 		$1.03M Buy
+6,958
New +$938K 0.01% 459
2015
Q4 		– Sell
-276,572
Closed -$22.2M – 151
2015
Q3 		$22.2M Buy
+276,572
New +$30.7M 0.39% 68

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

USS Investment Management's ALNY Position: Q2 2026 in Review

USS Investment Management increased its Alnylam Pharmaceuticals (ALNY) stake by 28% in Q2 2026, buying an estimated $2.31M and bringing the position to 34,492 shares worth $10.4M. The position accounts for 0.04% of the portfolio, ranked #294.

USS Investment Management first reported a position in ALNY in Q3 2015 and has held it in 26 quarters since. The position peaked at $22.2M in Q3 2015. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • USS Investment Management held 34,492 shares of Alnylam Pharmaceuticals worth $10.4M as of Q2 2026.
  • USS Investment Management bought 7,644 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.31M.
  • Alnylam Pharmaceuticals made up 0.04% of USS Investment Management's portfolio in Q2 2026, its #294 holding.
  • USS Investment Management first reported a position in Alnylam Pharmaceuticals in Q3 2015 and has held it in 26 quarters since.
  • USS Investment Management's Alnylam Pharmaceuticals position peaked at $22.2M in Q3 2015.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on USS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.